KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 0.17%.

  • West Pharmaceutical Services' Return on Capital Employed fell 100.0% to 0.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.18% for FY2024, which is 400.0% down from last year.
  • Latest data reveals that West Pharmaceutical Services reported Return on Capital Employed of 0.17% as of Q3 2025, which was down 100.0% from 0.18% recorded in Q2 2025.
  • West Pharmaceutical Services' 5-year Return on Capital Employed high stood at 0.29% for Q4 2021, and its period low was 0.17% during Q3 2025.
  • In the last 5 years, West Pharmaceutical Services' Return on Capital Employed had a median value of 0.22% in 2021 and averaged 0.23%.
  • In the last 5 years, West Pharmaceutical Services' Return on Capital Employed surged by 1000bps in 2021 and then crashed by -800bps in 2023.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Return on Capital Employed stood at 0.29% in 2021, then fell by -13bps to 0.25% in 2022, then dropped by -13bps to 0.22% in 2023, then dropped by -15bps to 0.18% in 2024, then decreased by -6bps to 0.17% in 2025.
  • Its Return on Capital Employed stands at 0.17% for Q3 2025, versus 0.18% for Q2 2025 and 0.18% for Q1 2025.